Weight gain prevention in women with polycystic ovary syndrome

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Obesity increases polycystic ovary syndrome (PCOS) prevalence and severity across metabolic, reproductive and psychological features. Weight management is the recommended first-line PCOS treatment and women with PCOS are at high risk of weight gain, but weight gain prevention program has not been trialled in this group. This study will assess the effect of metformin, a commonly prescribed drug for PCOS, and a low-intensity lifestyle program on weight gain women with PCOS.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutrition and Dietetics not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

fertility | nutrition | polycystic ovarian syndrome (PCOS) | weight control | women's health